Clinical Trial Update: The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of zoledronic acid to prevent cancer therapy-induced bone loss in breast cancer patients; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-09-07